

Daxin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.84 Cr
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 22.66 Cr
- Satisfied Charges ₹ 1.95 Cr
- Revenue Growth 22.14%
- Profit Growth 1388.04%
- Ebitda 51.54%
- Net Worth 14.68%
- Total Assets 10.44%
About Daxin Pharmaceuticals
Daxin Pharmaceuticals Private Limited (DPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 February 2014 and has a history of 11 years and three months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.84 Cr.
The company currently has active open charges totaling ₹22.66 Cr. The company has closed loans amounting to ₹1.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nikhil Jha and Sheela Jha serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100DL2014PTC264559
- Company No.
264559
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Feb 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Daxin Pharmaceuticals?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nikhil Jha ![]() | Director | 16-Feb-2014 | Current |
Sheela Jha ![]() | Director | 06-Feb-2014 | Current |
Financial Performance of Daxin Pharmaceuticals.
Daxin Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 22.14% increase. The company also saw a substantial improvement in profitability, with a 1388.04% increase in profit. The company's net worth Soared by an impressive increase of 14.68%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Daxin Pharmaceuticals?
In 2024, Daxin Pharmaceuticals had a promoter holding of 56.73% and a public holding of 43.27%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Daximed Healthcare Private Limited
Nikhil Jha and Sheela Jha are mutual person
Charges (Loans)
₹22.66 Cr
₹1.95 Cr
Charges Breakdown by Lending Institutions
- Others : 22.66 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 Apr 2024 | Others | ₹3.30 M | Open |
25 Nov 2021 | Others | ₹1.05 Cr | Open |
20 Nov 2020 | Others | ₹21.28 Cr | Open |
30 May 2015 | Others | ₹1.95 Cr | Satisfied |
How Many Employees Work at Daxin Pharmaceuticals?
Daxin Pharmaceuticals has a workforce of 78 employees as of Mar 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Daxin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daxin Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Daxin Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Daxin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge with Others of Rs. 21.28 Cr registered on 20 Nov 2020 with Charge ID 100402828 was modified on 25 Sep 2024.
- Charges
A charge with Others amounted to Rs. 0.33 Cr with Charge ID 100913441 was registered on 20 Apr 2024.
- Balance Sheet
Daxin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge registered on 30 May 2015 via Charge ID 10578019 with Others was fully satisfied on 04 Jan 2024.
- Charges
A charge with Others amounted to Rs. 1.05 Cr with Charge ID 100504861 was registered on 25 Nov 2021.
Frequently asked questions
What is the Incorporation or founding date of Daxin Pharmaceuticals Private Limited?
Daxin Pharmaceuticals Private Limited was incorporated on 06 Feb 2014.
What is authorized share capital and paid-up capital of Daxin Pharmaceuticals Private Limited?
The authorized share capital of Daxin Pharmaceuticals Private Limited is ₹ 10.00 Cr and paid-up capital is ₹ 9.84 Cr.
Who are the current board members & directors of Daxin Pharmaceuticals Private Limited?
Currently 2 directors are associated with Daxin Pharmaceuticals Private Limited.
- Nikhil Kumar Jha
- Sheela Jha
What is the registered address of Daxin Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Daxin Pharmaceuticals Private Limited is Office No-204 205 2Nd Floor Apra Dwarka Plaza-I Plot No-21 Sector-10, India, New Delhi, 110075.
What is the corporate identification number (CIN) and company number of Daxin Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Daxin Pharmaceuticals Private Limited is U24100DL2014PTC264559 and the company number is 264559 as per Ministry of Corporate Affairs (MCA).
What is the official website of Daxin Pharmaceuticals Private Limited?
The Official website of Daxin Pharmaceuticals Private Limited is https://www.daxinpharma.in
What has been the recent revenue trend for Daxin Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Daxin Pharmaceuticals Private Limited has risen by 22.14%.
How many employees does Daxin Pharmaceuticals Private Limited currently have?
As Per 2024 financial reports, 78 employees are currently employed by Daxin Pharmaceuticals Private Limited.
What change has been observed in the net worth of Daxin Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Daxin Pharmaceuticals Private Limited has experienced an upsurge of 14.68%.
What are the total open charges for Daxin Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Daxin Pharmaceuticals Private Limited amount to ₹ 22.66 Cr.
When was the last Balance Sheet of Daxin Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Daxin Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India